全文获取类型
收费全文 | 223篇 |
免费 | 12篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 1篇 |
妇产科学 | 1篇 |
基础医学 | 19篇 |
口腔科学 | 29篇 |
临床医学 | 21篇 |
内科学 | 63篇 |
皮肤病学 | 2篇 |
神经病学 | 12篇 |
特种医学 | 5篇 |
外科学 | 13篇 |
预防医学 | 14篇 |
眼科学 | 13篇 |
药学 | 33篇 |
中国医学 | 1篇 |
肿瘤学 | 8篇 |
出版年
2023年 | 4篇 |
2022年 | 7篇 |
2021年 | 17篇 |
2020年 | 7篇 |
2019年 | 6篇 |
2018年 | 9篇 |
2017年 | 5篇 |
2016年 | 8篇 |
2015年 | 7篇 |
2014年 | 11篇 |
2013年 | 15篇 |
2012年 | 17篇 |
2011年 | 14篇 |
2010年 | 6篇 |
2009年 | 13篇 |
2008年 | 20篇 |
2007年 | 19篇 |
2006年 | 16篇 |
2005年 | 7篇 |
2004年 | 8篇 |
2003年 | 8篇 |
2002年 | 7篇 |
2001年 | 1篇 |
1999年 | 1篇 |
1995年 | 1篇 |
1991年 | 1篇 |
1982年 | 2篇 |
排序方式: 共有237条查询结果,搜索用时 15 毫秒
81.
Electroencephalogram (EEG) gives researchers a non-invasive way to record cerebral activity. It is a valuable tool that helps clinicians to diagnose various neurological disorders and brain diseases. Blinking or moving the eyes produces large electrical potential around the eyes known as electrooculogram. It is a non-cortical activity which spreads across the scalp and contaminates the EEG recordings. These contaminating potentials are called ocular artifacts (OAs). Rejecting contaminated trials causes substantial data loss, and restricting eye movements/blinks limits the possible experimental designs and may affect the cognitive processes under investigation. In this paper, a nonlinear time-scale adaptive denoising system based on a wavelet shrinkage scheme has been used for removing OAs from EEG. The time-scale adaptive algorithm is based on Stein's unbiased risk estimate (SURE) and a soft-like thresholding function which searches for optimal thresholds using a gradient based adaptive algorithm is used. Denoising EEG with the proposed algorithm yields better results in terms of ocular artifact reduction and retention of background EEG activity compared to non-adaptive thresholding methods and the JADE algorithm. 相似文献
82.
Duygu Ozmadenci Jayanth S. Shankara Narayanan Jacob Andrew Marjaana Ojalill Allison M. Barrie Shulin Jiang Samhita Iyer Xiao Lei Chen Michael Rose Valeria Estrada Alfredo Molinolo Thomas Bertotto Zbigniew Mikulski Michael C. McHale Rebekah R. White Denise C. Connolly Jonathan A. Pachter Vijay K. Kuchroo Dwayne G. Stupack David D. Schlaepfer 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(17)
83.
84.
85.
Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. 总被引:1,自引:0,他引:1
Jayanth Panyam Manisha M Dali Sanjeeb K Sahoo Wenxue Ma Sudhir S Chakravarthi Gordon L Amidon Robert J Levy Vinod Labhasetwar 《Journal of controlled release》2003,92(1-2):173-187
The objective of the study was to investigate the effect of particle size of nano- and microparticles formulated from poly(D,L-lactide-co-glycolide) (50:50 PLGA) on polymer degradation and protein release. Since the surface area to volume ratio is inversely proportional to the particle size, it is hypothesized that the particle size would influence the polymer degradation as well as the release of the encapsulated protein. PLGA nano- and microparticles of approximate mean diameters of 0.1, 1 and 10 microm, containing bovine serum albumin as a model protein, were formulated using a multiple water-in-oil-in-water emulsion solvent evaporation technique. These particles were incubated at 37 degrees C in phosphate-buffered saline (pH 7.4, 154 mM) and the particles were characterized at various time points for molecular weight of polymer, surface-associated polyvinyl alcohol content (PVA), and the particle surface topology using scanning electron microscopy. The supernatants from the above study were analyzed for the released protein and PVA content. Polymer degradation was found to be biphasic in both nano- and microparticles, with an initial rapid degradation for 20-30 days followed by a slower degradation phase. The 0.1 microm diameter nanoparticles demonstrated relatively higher polymer degradation rate (P<0.05) during the initial phase as compared to the larger size microparticles (first order degradation rate constants of 0.028 day(-1), 0.011 day(-1) and 0.018 day(-1) for 0.1, 1 and 10 microm particles, respectively), however the degradation rates were almost similar (0.008 to 0.009 day(-1)) for all size particles during the later phase. All size particles maintained their structural integrity during the initial degradation phase; however, this was followed by pore formation, deformation and fusion of particles during the slow degradation phase. Protein release from 0.1 and 1 microm particles was greater than that from 10 microm size particles. In conclusion, the polymer degradation rates in vitro were not substantially different for different size particles despite a 10- and 100-fold greater surface area to volume ratio for 0.1 microm size nanoparticles as compared to 1 and 10 microm size microparticles, respectively. Relatively higher amounts of the surface-associated PVA found in the smaller-size nanoparticles (0.1 microm) as compared to the larger-size microparticles could explain some of the observed degradation results with different size particles. 相似文献
86.
87.
Ketogenic diet (KD) is used to manage intractable epilepsy; however, the mechanisms underlying its therapeutic effects are not known. Steroid hormones, such as progesterone and testosterone, are derived from cholesterol, and are readily 5alpha-reduced to dihydroprogesterone and dihydrotestosterone, which are subsequently converted to 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) and 3alpha-androstanediol, neuroactive steroids that can influence seizures. The present study examined the effects of the KD on circulating concentrations of these neuroactive steroids, and their precursors, in intact female rats. Thirty-six, 22-day-old female Sprague-Dawley rats (weaned at 21 days) were fasted for 8 hours prior to placement on one of three dietary regimens for 6 weeks: ad libitum chow, calorie-restricted chow, or KD. After 6 weeks of the diet, when six rats in each dietary condition were in diestrus and six were in behavioral estrus, all rats were administered pentylenetetrazole (PTZ, 70 mg/kg, i.p.). The latency and incidence of seizures were recorded by an observer who was uninformed of the estrous cycle and dietary treatment conditions of the rats. Immediately after each test, trunk blood was obtained for later measurement of pregnane (progesterone, dihydroprogesterone, 3alpha,5alpha-THP) and androstane (testosterone, dihydrotestosterone, 3alpha-androstanediol) neuroactive steroid concentrations in plasma by radioimmunoassay. KD tended to lengthen the latency to, and significantly reduced the number of, PTZ-induced barrel roll seizures. KD also significantly reduced plasma levels of the pregnane (dihydroprogesterone, 3alpha,5alpha-THP) and androstane (dihydrotestosterone, 3alpha-androstanediol) 5alpha-reduced metabolites. These data suggest that levels of pregnane and androstane neuroactive steroids, or their precursors, may underlie some of the antiseizure effects of KD. 相似文献
88.
89.
90.
Theodoros D. Karamitsos Jayanth R. Arnold Tammy J. Pegg Adrian S. H. Cheng William J. van Gaal Jane M. Francis Adrian P. Banning Stefan Neubauer Joseph B. Selvanayagam 《The international journal of cardiovascular imaging》2009,25(3):277-283
We sought to assess the tolerance and safety of adenosine-stress cardiovascular magnetic resonance (CMR) perfusion imaging
in patients with coronary artery disease (CAD). We retrospectively examined all adenosine CMR perfusion scans performed in
our centre in patients with known or suspected (CAD) and normal volunteers at either 1.5 or 3 T. All subjects were initially
screened for contraindications to adenosine. The dose of adenosine infused was 140 μg/kg/min. Significant CAD was defined
angiographically as the presence of at least one stenosis of >50% diameter. Data were collected from 351 consecutive subjects
(mean age 62 ± 11 years, range 25–85 years-245 men). Of the 351 subjects, 305 had a coronary angiogram, the remaining 46 subjects
were normal volunteers studied for research protocols. In total, 233 subjects (76%) were found to have significant CAD of
whom 128 had multi-vessel disease. There were no deaths, myocardial infarctions, or episodes of bronchospasm during the CMR
study. Transient 2nd (Mobitz II) or 3rd-degree atrioventricular (AV) block occurred in 27 patients (8%). There were no sustained
episodes of advanced AV block. Transient chest pain was the most common side effect (199 subjects—57%). The use of intravenous
adenosine in CMR perfusion imaging is safe and well-tolerated, even in patients with severe CAD. Where a careful screening
policy for contraindications to adenosine is followed, serious adverse events in the CMR scanner are relatively rare and symptoms
resolve following termination of the infusion, without the need for aminophylline. 相似文献